By a News Reporter-Staff News Editor at Investment Weekly News -- Safeguard Scientifics, Inc. (NYSE:SFE) announced first quarter 2014 financial results. For the three months ended March 31, 2014, Safeguard's net income was $31.3 million, or $1.44 per share, compared to a net loss of $11.9 million, or $0.57 per share for the same period in 2013.
"Safeguard continues to create shareholder value through a disciplined execution of our strategic business model," said Stephen T. Zarrilli, President and CEO at Safeguard. "During the quarter, we led a $17 million Series B financing for InfoBionic, an emerging digital health company headquartered in Massachusetts. Subsequent to the quarter, Safeguard sold its ownership stake in Sotera Wireless for $4.2 million in cash proceeds, representing a 1.5x cash-on-cash return for Safeguard. Our momentum remains strong and opportunities abound for additional M&A and value creation events in the future."
"As of March 31, 2014, Safeguard deployed $177 million of capital into its 20 partner companies," said Jeffrey B. McGroarty, Senior Vice President and Chief Financial Officer at Safeguard. "Our net cash, cash equivalents and marketable securities totaled $191.5 million, after subtracting the total carrying value of debt outstanding of $50.2 million. As a result of net proceeds from our recent exit transactions, Safeguard has exceptional financial strength, flexibility and liquidity." SHARE REPURCHASE PROGRAM During the first quarter of 2014, Safeguard repurchased 388,404 shares of the Company's common stock in open market transactions at prices ranging from $19.54 to $22.08 per share for an aggregate cost of $8.0 million. Since the close of the first quarter, Safeguard has repurchased an additional 594,700 shares for an aggregate cost of $12.5 million, bringing total repurchases to 983,104 shares for $20.5 million through April 24, 2014.
In February 2014, Safeguard's Board of Directors approved an increase in the Company's share repurchase program, bringing the total authorization to $25 million. Until the aggregate repurchase authorization has been utilized, share repurchases may be made from time to time, based on ongoing capital needs of the business, the market price of our common stock, and general market conditions. No time has been set for the completion of the repurchase program, and the program may be suspended or discontinued at any time. PARTNER COMPANY AGGREGATE REVENUE GUIDANCE Partner company aggregate revenue in 2014 is projected to be between $345 million and $365 million. Aggregate revenue for the same partner companies was $284 million in 2013 and $201 million in 2012. Aggregate revenue guidance for 2014 and prior years reflects revenue on a net basis. Revenue figures utilized for certain companies pertain to periods prior to Safeguard's involvement with those companies and is based solely on information provided to Safeguard by such companies. Safeguard reports the revenue of its equity and cost method partner companies on a one-quarter lag basis. PARTNER COMPANY HIGHLIGHTS KEY: Safeguard Partner Company Revenue Stages Development Stage Pre-revenue Proving out technology Developing prototype Beta stage customers
Initial Revenue Stage $0M to $5M in annual revenue Initial customers Early market penetration Management team forming Infrastructure being built
Expansion Stage $5M to $20M in annual revenue Commercial grade solution Growing market penetration Management team built out Infrastructure in place
High Traction Stage $20M+ in annual revenue Significant commercial traction
Keywords for this news article include: Banking and Finance, Investment and Finance, Safeguard Scientifics Inc.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC